Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

K. Sreedhara Ranganath Pai

K. Sreedhara Ranganath Pai, PhD, is professor, epartment of Pharmacology, Manipal Academy of Higher Education

Articles by K. Sreedhara Ranganath Pai

Close-up of tubes in Brookhaven National Laboratory | Image Credit: © Bill Gallery - © Bill Gallery - stock.adobe.com

Application of the Risk Evaluation Matrix as per USP <665> and <1665> for Evaluation of Leachables Risk from Single-Use Components Used in Biomanufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee ,Somasundaram Gopalakrishnan,Tathagata Ray

June 6th 2024

Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.

bag of medical serum | Image Credit: © mailsonpignata - © mailsonpignata- Stock.adobe.com

Review of SUT Adoption in Biopharma Manufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee,Somasundaram Gopalakrishnan,Tathagata Ray

March 15th 2024

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Latest Updated Articles

Trending on BioPharm International

AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform

Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial

The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide

Efinopegdutide Meets Primary Endpoint in Phase 2b MASH Trial

ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months